Philip Morris
A Novel Method for the Isolation and Quantitative Analysis of Nicotine and Cotinine in Biological Fluids
Fields
- Author
- Caton, J.E.
- Harvey, R.W.
- Maskarinec, M.P.
- Harvey, R.W.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- ABST, ABSTRACT
- Area
- CENTRAL FILES/PRE-DB WAREHOUSE
- Site
- R107
- Named Organization
- Borr, Borriston Labs
- Southwest Research Inst
- Request
- Stmn/R1-119
- Named Person
- Buhl, P.
- Rodgers, W.
- Master ID
- 2021574528/4793
Related Documents:- 2021574528 Federal Trade Commission, Plaintiff, V. Brown & Williamson Tobacco Corp., Defendant. Exhibits Annexed to Declaration of Wallace S. Snyder in Support of Plaintiff's Motion for Preliminary Injunction Volume I Exhibits 1 - 15
- 2021574529 Exhibit 1
- 2021574530 Notices Federal Trade Commission Cigarettes Testing for Tar and Nicotine Content
- 2021574531-4533 Statement of Considerations
- 2021574534-4536 Separate Statement of Chairman Dixon
- 2021574537 Exhibit 2
- 2021574538 Proposed Rule Making Advertising of Cigarettes Notice of Public Hearing and Opportunity to Submit Data, Views, or Arguments Regarding Proposed Trade Regulation Rule
- 2021574539 Exhibit 3
- 2021574540-4541
- 2021574542-4546
- 2021574547-4551 Explanatory Memorandum Relating to Voluntary Program for 'tar' and Nicotine Disclosure
- 2021574552
- 2021574553 Exhibit 4
- 2021574554 Proposed Rule Making Advertising of Cigarettes Notice of Suspension of Trade Regulation Proceeding
- 2021574555 Exhibit 5
- 2021574556-4557 Cigarette Advertising and Other Promotional Practices Announcement of Decision
- 2021574558 Exhibit 6
- 2021574559
- 2021574560 Agenda
- 2021574561-4578 Test Brands
- 2021574579 Exhibit 7
- 2021574580-4583
- 2021574584 Exhibit 8
- 2021574585 Cigarette Testing
- 2021574586 Exhibit 9
- 2021574587-4588
- 2021574589 Exhibit 10
- 2021574590-4594 Implications of Barclay Filter on Ftc 'tar' Testing Program
- 2021574595 Exhibit 11
- 2021574596
- 2021574597-4627 Memorandum to the Federal Trade Commission From Philip Morris Incorporated Concerning Barclay Cigarettes and A Proposed Change in the Apparatus Used in the Commission's Laboratory for Testing 'tar' Delivery
- 2021574628 Exhibit 12
- 2021574629-4646
- 2021574647 Smokers Tested by Dr. Roger Kamm
- 2021574648 Cain Butt Study
- 2021574649-4650 Smoke Panel Evaluations of Parclay Ks, Now Ks, and Carlton Ks with 'extended' Rigid Sleeves Around the Filter
- 2021574651-4668 20. Smoking Behaviour in Germany - the Analysis of Cigarette Butts (Kipa)
- 2021574669-4671 Puffing Frequency and Nicotine Intake in Cigarette Smokers
- 2021574672-4702 Memorandum to the Federal Trade Commission From Philip Morris Incorporated Concerning Barclay Cigarettes and A Proposed Change in the Apparatus Used in the Commission's Laboratory for Testing 'tar' Delivery
- 2021574703 Exhibit 13
- 2021574704-4714 Investigation of Barclay Filter
- 2021574715-4720 Animal Inhalation Studies with Tobacco Smoke (A Review)
- 2021574721-4732 14. The Analysis of Smoking Parameters: Inhalation and Absorption of Tobacco Smoke in Studies of Human Smoking Behaviour
- 2021574733-4737 the Case for Medium - Nicotine, Low - Tar, Low Carbon Monoxide Cigarettes
- 2021574741-4743 Verification of Smoking History in Parents After Inaction Using Urinary Nicotine and Cotinine Measurements
- 2021574744-4747 Smoking, Carbon Monoxide and Arterial Disease
- 2021574748 Exhibit 14
- 2021574749-4752
- 2021574753 Exhibit 15
- 2021574754-4755 Investigation of Barclay Filter
- 2021574756-4792 Supplemental Memorandum to the Federal Trade Commission From Philip Morris Incorporated Concerning Measurement of the Relative 'tar' Deliveries of Barclay and Other Cigarette Brands Through Analysis of Retained Nicotine in Cigarette Butts
- 2021574793
- Author (Organization)
- Journal of Analytical Toxicology
- Oak Ridge Natl Lab
- Litigation
- Stmn/Produced
- Characteristic
- MARG, MARGINALIA
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- pyg34e00
Document Images
1
A Novel Method for the Isolation and
~. .
a
1
)
!
'.Quantitative Analysis of Nicotine and
Cotinine in Biological Fluids/*
~' Laboratory, Oak Ridge, Tennessee 37830
\
NOTICE .
This m=t:r.al may bs
Ixotcatad Ly e.plri=ht
law (TiiIP 17 U.S. Code):_
~~ M.P. Maskarinec, R.W. Harvey, and J.E. Caton,Analytical Chemistry Division, Oak Ridgt: National
Abstract
A rapid quantttatlve method has be.n developed for the
esllmatton of nicotine and eottntn. In blood and urine. Isots-
tton Is aeeom;ltshed by adsorptlon of the alkaloids on Amber-
tite XAO.2 ristn and subsequent Nutlon with chtorotorm/
methanol. No sotvent extraction or further purUieaUoa Is
requtred. The flnal determinatton Is mad. by high perform
ance liquid chromatography using UV drateetlon. Absolute
recovery of nicottne was at least tlOX In aU samples. The
accuracy of the method Is-ostlmated to be = 5% on standard
addition measurements. Dal.ctton limits of 2 ng/ml urine
may beTouttnely obtatned. _
Introduction
The adsorptior.; distribution, and metabolism of nicotine
have been investigated in a variety of animal species (I-3), as
have the pharmxological_a_ctions of this tobacco alkaloid (4).
However, in spite of the widespread use of tobacco products,
there exists no simrle quantitative method for the detcrmina-
tien of nicotine and cotinine, its major metabolite, in body
fluids. Previous methods for nicotitie and cotinine in urine
and su am ttave relied mainly on solvent partition schemes for
isolation and purifiatioit, while the final determination is
made by gas chromatography, using conventional ilame iotti-
zation detection (S-7), nitrogen-sclectire detection (8,9) or.
deetron capture detection (10). While the sensitivity of these
methods has been entirely;sufficient, the isolation schemes
have been generally non-reproducible and tedious. In
addition; total analysis times have been rather long. The
advent of High-Performance Liquid Chromatography
(HPLC) as a rapid, reliabie analytical tool has led to the
development of a method for the estimation of nicotine and
cotinine by HPLC using UV detection (11). This method also
employed solvent partition for isolation. Earlic* work on the
screening of urine for basic Q'rugs of abuse by adsorption onto
Amberlite XAD-2 (12) led us to `.nvestigate the practicality of
Rescarch sponsored by the Natinnat t'ancer lustitute under lnter.
agency A=reemenCNtfl :NC1) 40-+tLS-74 under l7ninn Carbide Cnrp-
oration contraa W-740S:zg-2b with the L'.=. Departmennot Energy.
Send reprint requests to: M.P. Maskarinec. Aralyticat Chemistry
Division. Oak Ridge National Laboratory. P.O. boa ::. Oak Ridge. TN
37830. Z -
124JULY/AUGUST 1975
this approach to the rapid quantitative isolation of nicotine
and its metabolites from body fluids, while relying on HPLC
for the final determination.
.
Materials and Methods
. ~
Amberlite XAD-2 was obtained in prefillcd; precleaned
columns (Isolab, Inc., Akron, OH). "C-nicotinc was obtained
frorn Amersham Ine.. Arlington faeights, IL- "C-cotinine (13)
and nictxine-I-N.oxide (14) were synthesized according to
established procedures. Nornicotinc was obtained from Pfeliz
& Bauer. Flushing, NY. A Packard Tri-Carb Model C2425
Liquid Scintillation Counter was used for recovery
experiments. Liquid chromatography was done using a\Vaters
Model ALC-202 isoeratic liquid " chromatograph equipped
with a Rhcodyne sample injector and a UV absorbance
detector (254 nm). Columns were 25 cm by 4.6 mm i4
Zorbax-Sil (Dupont). All solvents were spectro-quaGty or
better.
Urine (20 ml) was adjusted to pH 9 with saturated NH,Ci
buffer (pH 10). Plasma (1-5 ml) was diluted to )0 ml using a
)0°fs saturated buffer. "C-nicotinc (0.27 pCi) was added to
each sample to measure recovery. Ten ml of the 101re buffer
solution was allowed to flow through the XAD-2 column for
equilibration. The sample was then passed through the column
at a flow rate of approximately 2.5 mI/min. After a second
wash with 10S's NH4C1 buffer (15 ml), the alkaloids were
eluted with I ml acetone, foilowed by 20 ml methanol/chloro-
form (I:3). The eluate was biphasic. The upper (methanol)
layer was discarded, and the lower (ch'oroform) layer gently
evaporated to dryness after removal of a SO-Nt aliquot for
liquid scintillation counting. The residue was redissolved in
200 pl dioxanersopropanol/NI+M'40Ii (50:3:0.4), x"hich was
alxo used as the mobile phase. A 20-p1 aliquot was applied to
the liquid chromatographic system and cluted at a Iflow rate of
1.0 ml/mia.
Results and Discussion
.. Six replicate analyses of urine samples indieatcd a mean
recovery (after evaporation) of 8S.7r,'s for nicotine and 86.4%
for cotinine, with standard deviations of 4.6?'# and 0.93°.r.,
respectiveiy,u shown in Table 1. Adsor;.tion of both nicotine
JOURNAL OF ANALYTICAL TOXICOLOGY-VOL. 2

o-.-ac n 1ofo
Table I. Recovery ot "C-Nicotln and "C-Cotintne from
' . Urine g.l r.l . .
Nicotine Cotinine ®
I Detet7ninations 6 6
/
7. Unretained 03.69 = 5.10 01.14 10.28 Y
I i ,
1
% In Methanol 04.20 s 0.47 03.87 t 0.29
9. Chloroform 86.50 s 0.48 86.80 s 0.49
.
!. Recovered After 85.70 = 4.80 86.40 s 0.98
1
)
)
?
)
Evaporation
Units are 9r =1 Standard Deviation.
and cotinine on the XAD-2 was virtually quantitative. While
the alkaloids partitioned between chloroform and methanol
approximately 95:5, the urinary pigments (which would be
expected to interfere in the final determination) were parti-
tioned into the methanol phase. The accuracy or the method
was determined by standard addition of nicotine to a urine
sample in which no nicotine was detected (<2 ng/mI). The
results are shown in Figure 1. Over the range 10 ng/ml - 10
jtg(ata all determinations were within SRo or the correct value.
.Evpt at a level of 10 pg/mb. no significant breakthrough of
nicotine on the XAD-2 columns was observed.
STANDRRD EIDDITIDN OF NICOTINE TO URINE
Figure 1. Results of standard addition of nicotine to urine.
A comparison of the liquid chromatograms of the urinary
extracts of a smoker and non-smoker is shown inFigure 2. In
addition to the.nicotine and cotinine peaks. nornicotine was
also tentatively identified (by retention time comparison with
an authentic standard) in the smoker's urine. The levels in this
individual (a heavy smoker of non-filter cigarettes) were 247
ng/ml nicotine and 521 nj/mI cotinine (after recovcry eorrea
tion). The nicotine level in the non-smoker was 7 ng/ml while
0
r
7 iT''-1' T l"! I t t i~ t- t T t t-.........
o a . i 6 0 oa N $60 2 4 . 0 to .2 0. 14
Iw(1r1
TT~Z'Try-TTT1 T`1 t-TT:Z.' . . t . . . . . .
0 2 6 . 6 1 40 Q 44 06 0 2 4 6 a 0 ot 04 K
tlYr10M. WlNK M)
Figure 2. Comparison of liquid chromalograms of the
alkaloids from the urine of a smoker (a) and a non-smoker(b).
Conditions: column-Zorbax-Sil (Dupont) 25-cm r 4.6-mm
i.d.;' flow rat. 1.0 mi/min; detector - UV (254 nm);
sensitivity - .16 AUFS..
the cotinine level was below the detection limit of the method
(2 ng/ml).
The extracts were further analyzed by glass capillary gas
chromatography on a 50-m x 0.26-mm i.d. OV-10] column
using simultaneous non-selective (FID) and nilrogen-selcctive
(NPFID) detection (Perkin-Elmer Model 3920 Gas Chroma-
tograph). The results were within ST's of those obtained by
HPLC.
To further test the validity of the method, a series or urine
samples from smoking baboons were analyzed (blind) for
nicotine and cotinine,and'the results were in close agreement
(p <.05) with those obtained in a separate laboratory by gas
chromatography-mass spectrometry (1 S).
While urinary levels of nicotine and its metabolites are
important in screening for cigarette smoking and in determin-
ing total smoke dose, it was of interest to examine the
possibility of determining plasma nicotine levels by this
method. Recovery of plasma nicotine was found to be similar
to the urinary recovery. A typical liquid chroinatogram ob-
tained from a S-rni plasma sample of a dog cxposed to
cigarette smoke is shown in Figure 3. The recovery corrected
nicotine level in this case was found to be 112 ng/ml.
.~- twcie~t e ~
r ar.. .
'
ddertn ~ti
~i~~t~
Conclusions
A method has been developed which allows tht rapid,
quantitative determination of nicotine and its metabolites in
physiological fluids. The method has been applied to the.
measurement of urinary levels of nicotine and its metabolites
in humans and smoking baboons and also to the study of
plasma nicotine levels in dogs exposed to cigarette smoke. The:
simplicity and rapidity of the method allows up to 40
samples/day to be conveniently run by one technician.
Therefore, the method should find wide applicability in I kbo-
ratories involved in nicotine screening on a routine basi:. In
,oases where radioactive tracers are not readily available, a
suitable internal standard may be added for recovery measure.
ment: One such compound is desmcthylimipraminc (11).
~
1
JCURNALOF ANALYTICAL TOXICOLOGY-VOL. 2 JULY/AUGUST 1975-125

:
~
....
t a
)
I
.
0 2 4 6 6 10 12 /4 .1i
TtME to"
0 2 4 6 e /0 12 14 16
ELuTION vOLUME ta.t1
Ftgure 3. LlQuid chromatogram of nicotine Isolated from 5 ml
dog plasma. Conditions: as In Figure 2. Sensitivity .08
AUFS.
Acknowledgment
The authors wish to thank Dr. Patricia Buhl (Borriiton
Research Lab, Temple Hills, MD) for supplying the dog plas-
ma samples and Dr. Walter Rodgers (Southwest Research
Institute, San Antonio, TX) for the baboon urines.
Manusaipcreceived June 16, )978
1.P. Jcnner. J.W. Gorrod. and A.H. Ilcckett. Factors affecting the
in vitro metabr of R-(i)- and S-(+nicotine by 6uincapiY .
liver preparation. .,'ennbiaice. 3 (9): 563S72 (1973).
2. P. Jenner, J.W. Gorrod. and A.H. Ueckett. Species variation in
the metabofismorR-(+)-and SH- nieotine bya-C- and N-oaida-
tion in vitro. Xenobiotica 3(9): S73-580 (1973).
3. P. Jcnner and J.W. Gorrod. Comparative in vitro liepatic metabo-
lism of some tertiary Nmethyl tobacco alkaloids in various
species. Res. Coerar. CFere. Path. and PhereraroL 6 (3): E29-b43
(1973).
4. M.S.G. Clark. M.J. Rand. and S. Vanov. Comparison of
pharmacological activity of nicotine and related alkaloids occur _
ing in cigarette smoke.Arrlk. lnt. Pbsrnrocady>,.aTAerap. 156 (2):
363-379 (1965).
S. A.H. Beckett and EJ. Triggs. Determination of nicotine and its- .
mctaboiite. cotinine. ia nrine by gas chromatography. Nat,.re.
211: 14t51417 f 1966).
6. H. Schievelbein and K. Grundke. Gas-chromatotraphische
methode zur bestimmung von nicotine in blut and geaeben. Z
Awal. Clatm. 237:1-b(196a). -
7. !.E Burro.s. PJ. Corp. G.C. Jackson. and B.FJ. Page. The
determination of nicotine in human blood by gas-liquid chroma
tography. Awofyst 96: 81-8/(1971).
g. P.F. Isaac and MJ. Rand. Cigarette smoking andplasma levels
of nicntine. Natyrc 736: 306-310 (1972).
9. C. Dumas, R. Badre. A. Viala. J: P.Cano and R. Guillerm. Alicro-
methode de determination de la nicotine et de Is continine dans Ie
sang et 1'urine par chromato`nphie en phase gazeuse. Resultats
obteaus ehez divers fumeurs. Ear. J. TozieoL 8(5): 280286
(1975).
10. L Nedakantan and H.B. Kostenbauder. Electron capture
derivative for determination of nicotine in subpicomole quan-
tities. AnoL Chem. 46 (3): 452-454 (1974).
11. lan D. Wat.son. Rapid analysis of nicotine and cotinine in the.
urine of smokers by high-performance liquid chromatography. l.
Chroareropr. 143:203-206 (1977).
12. M.P. Kullberg and C.W. Gorodctsky. Studies on the uie of
XAD-2 resin for detection of abused drugs in urine. CGn. CAe,n.
20 (2): 177.183 (1974).
13. E.C. Taylor and N.E. Borcr. Pyridine-loxides. IV. Nicotine1-
oside. Nlcotine1'oside. and N'rcotine1.1'dioaide.J. Org. t'ieni.
24: 275277 (1959).
14. E.R. Bowman arid H. McKennis. Jr. (-)Cotinine. Biacheer.
PreP. 10: 3639 (1959).
15. W. Rogers: Personal Communication (1978).
.
128JULY/AUGUST 1978
JOURNAL OF ANALYTICAL TOXICOLOGYYOL. 2
